Home | | | Search | | | Browse | | | Resources | | | Help | | | What's New | | | About |
---|
The following U.S. government web sites guide consumers to answers to questions and provide contacts to clinical trials, and to information on drugs and important health care issues. The clinical trials discussed in these sites are all available in ClinicalTrials.gov.
Clinical Trials at the National Institutes of Health.The NIH Clinical Center in Bethesda, Maryland is the research hospital of the National Institutes of Health (NIH). There, through clinical research, scientific discoveries in the laboratory are translated into new and better medical treatments and therapies for people.
Their web site guides potential participants, their families and physicians about participating in clinical trials in Bethesda, Maryland:
http://www.cc.nih.gov/
The National Cancer Institute (NCI) is the U.S. government's
focal point for clinical trials on cancer. Most U.S. government agencies that conduct cancer research, such as DOD or VA, do so in partnership with NCI.
http://www.nci.nih.gov/
NCI Clinical Trials Education Series provides publications for individuals and health care professionals to understand clinical trials, such as self-paced workbooks, slide programs on CD-ROM, booklets and videos:
http://www.nci.nih.gov/clinicaltrials/resources/clinical-trials-education-series
The Veterans Administration (VA) and NCI provide information on their interagency partnership agreement in clinical trials for
cancer:
http://www.va.gov/cancer/
The FDA Cancer Liaison Program, Office of
Special Health Issues with NCI answers questions directed to FDA by participants, their families, and participant advocates about therapies for life-threatening
diseases:
http://www.fda.gov/oashi/cancer/cancer.html
The National Eye Institute (NEI) provides a clinical studies database, vision research information, and free education resources:
http://www.nei.nih.gov/resources/
National Institute of Mental Health (NIMH)
supports FAQs for potential participants in mental health research; read "A
Participant's Guide to Mental Health Clinical Research":
http://www.nimh.nih.gov/Publicat/clinres.cfm
NIH Office of Extramural Research (OER), and the NIH
Inter-Institute Bioethics Interest Group
OER provides information on policies and regulations, Institutional
Review Board resources, guidance for clinical investigators, research
resources, courses and tutorials on bioethical issues in human studies:
http://www.nih.gov/sigs/bioethics/
The National Library of Medicine (NLM) compiled a comprehensive bibliography from 1989 through November 1998, "Ethical Issues in Research
Involving Human Participants,"compiled by the National Library of
Medicine:
http://www.nlm.nih.gov/pubs/cbm/hum_exp.html
HHS Office of Human Research Protection (OHRP)
OHRP provides a guide and training materials on regulations and procedures governing research with human subjects; includes a guidance document on financial relationships in clinical research:
http://www.hhs.gov/ohrp/
CMS provides information on the September 19, 2000 final national coverage decision regarding Medicare payments for routine costs, and reasonable and necessary items in clinical trials; read "Medicare Coverage Policy ~ Clinical Trials." This decision is based upon the authority found in §1862(a)(1)(E) of the Social Security Act
http://www.medicaid.com/coverage/8d2.asp
Clinical Trials and Medicare Quick Reference Guide
http://www.medicaid.com/medlearn/refctmed.asp
MedlinePlus is a web-based information service from the National Library of Medicine. Its "Health Topics" section has extensive information from NIH and other trusted sources on over 550 diseases and conditions, including a link to clinical trials. It also includes an informative "Clinical Trials" health topic page, with some material in Spanish, and an interactive tutorial on clinical trials.
http://www.nlm.nih.gov/medlineplus/clinicaltrials.html
The Food and Drug
Administration is the U.S. government agency responsible for ensuring the safety and
effectiveness of all drugs. After a clinical trial, it looks at the evidence to determine if a new drug or treatment is safe to approve as a marketable new product and is an improvement
over the standard therapy (See Approved Drugs). FDA web sites provide valuable information
to consumers on its activities in regulation and approval of drugs.
http://www.fda.gov/
Information on how drugs are developed in the U.S., read "From
Test Tube to Participant: New Drug Development in the U.S.," third Edition,
September, 1999:
http://www.fda.gov/cder/about/whatwedo/testtube.pdf
FAQs to CDER:
http://www.fda.gov/cder/about/faq/
The FDA Electronic Orange Book, which gives current approved
drug products:
http://www.fda.gov/cder/ob/
MedlinePlus Guide to over 9,000 prescription and over-the-counter
medications:
http://www.nlm.nih.gov/medlineplus/druginformation.html
U.S. National Library of Medicine, Contact NLM Customer Service | ||||||||||||||
National Institutes of Health, Department of Health & Human Services | ||||||||||||||
Copyright, Privacy, Accessibility, Freedom of Information Act |